Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir PEP Duration in Children
NCT04297462Unknown
- Sponsor
- Centrum Medyczne Kształcenia Podyplomowego
- Start
- Nov 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of oseltamivir in influenza (2 arms), sponsored by Centrum Medyczne Kształcenia Podyplomowego. Primary endpoints: Postexposure chemoprophylaxis efficacy, Oseltamivir safety and 1 more. Status: unknown.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04297462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04297462.